恐怖症(フォビア):グローバル臨床試験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Phobia Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Phobia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Phobia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Phobia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Phobia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Phobia Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Bluefish Pharmaceuticals AB 34
Clinical Trial Overview of Bluefish Pharmaceuticals AB 34
Forest Laboratories, Inc. 35
Clinical Trial Overview of Forest Laboratories, Inc. 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Extinction Pharmaceuticals, Inc. 37
Clinical Trial Overview of Extinction Pharmaceuticals, Inc. 37
DaVita HealthCare Partners Inc. 38
Clinical Trial Overview of DaVita HealthCare Partners Inc. 38
Avera Pharmaceuticals, Inc. 39
Clinical Trial Overview of Avera Pharmaceuticals, Inc. 39
Apsen Farmaceutica SA 40
Clinical Trial Overview of Apsen Farmaceutica SA 40
Clinical Trial Overview of Top Institutes / Government 41
The University of New South Wales 41
Clinical Trial Overview of The University of New South Wales 41
National Institute of Mental Health 42
Clinical Trial Overview of National Institute of Mental Health 42
Charite – Universitatsmedizin Berlin 43
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 43
University of South Florida 44
Clinical Trial Overview of University of South Florida 44
Umea University 45
Clinical Trial Overview of Umea University 45
Massachusetts General Hospital 46
Clinical Trial Overview of Massachusetts General Hospital 46
Weill Cornell Medical College 47
Clinical Trial Overview of Weill Cornell Medical College 47
Karolinska Institute 48
Clinical Trial Overview of Karolinska Institute 48
University of California, Los Angeles 49
Clinical Trial Overview of University of California, Los Angeles 49
New York State Psychiatric Institute 50
Clinical Trial Overview of New York State Psychiatric Institute 50
Five Key Clinical Profiles 51
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82


【レポート販売概要】

■ タイトル:恐怖症(フォビア):グローバル臨床試験動向(2014年上半期)
■ 英文:Phobia Global Clinical Trials Review, H1, 2014
■ 発行日:2014年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2226CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。